HIV DNA vaccine - LadRx Corporation
Alternative Names: DP-6001Latest Information Update: 29 Sep 2022
At a glance
- Originator Advanced BioScience Laboratories; University of Massachusetts Medical School
- Developer Advanced BioScience Laboratories
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 23 Sep 2022 CytRx Corporation is now called LadRx Corporation
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in USA (Parenteral)
- 31 Jul 2006 Final results from a phase I study have been added to the adverse events and Viral Infections immunogenicity sections